Concepts (163)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genetic Testing | 11 | 2021 | 1056 | 1.390 |
Why?
|
| Education, Medical, Undergraduate | 2 | 2021 | 156 | 0.930 |
Why?
|
| Genetic Counseling | 3 | 2018 | 233 | 0.680 |
Why?
|
| Financing, Personal | 1 | 2020 | 14 | 0.650 |
Why?
|
| Ehlers-Danlos Syndrome | 1 | 2018 | 49 | 0.560 |
Why?
|
| Ambulatory Care Facilities | 1 | 2020 | 235 | 0.550 |
Why?
|
| Autism Spectrum Disorder | 5 | 2021 | 423 | 0.520 |
Why?
|
| Students, Medical | 1 | 2021 | 337 | 0.520 |
Why?
|
| Parents | 5 | 2020 | 1078 | 0.510 |
Why?
|
| Schools, Medical | 2 | 2021 | 108 | 0.500 |
Why?
|
| Genomics | 6 | 2021 | 1548 | 0.500 |
Why?
|
| Health Knowledge, Attitudes, Practice | 6 | 2020 | 885 | 0.500 |
Why?
|
| Patient Satisfaction | 1 | 2018 | 456 | 0.450 |
Why?
|
| Quality Improvement | 1 | 2018 | 684 | 0.380 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2013 | 81 | 0.370 |
Why?
|
| Genes, Retinoblastoma | 1 | 2011 | 21 | 0.360 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2012 | 85 | 0.360 |
Why?
|
| Retinoblastoma Protein | 1 | 2011 | 76 | 0.350 |
Why?
|
| Genetics | 1 | 2011 | 24 | 0.350 |
Why?
|
| Muscle Weakness | 1 | 2012 | 86 | 0.350 |
Why?
|
| Health Services Needs and Demand | 1 | 2012 | 168 | 0.350 |
Why?
|
| Muscular Atrophy | 1 | 2012 | 74 | 0.350 |
Why?
|
| Retinoblastoma | 1 | 2011 | 79 | 0.340 |
Why?
|
| Camurati-Engelmann Syndrome | 1 | 2010 | 2 | 0.340 |
Why?
|
| Retinal Neoplasms | 1 | 2011 | 68 | 0.340 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 2012 | 113 | 0.340 |
Why?
|
| Cataract | 1 | 2012 | 144 | 0.330 |
Why?
|
| Ovary | 2 | 2016 | 358 | 0.330 |
Why?
|
| Bone Diseases, Developmental | 1 | 2010 | 60 | 0.320 |
Why?
|
| Health Educators | 2 | 2020 | 7 | 0.310 |
Why?
|
| Hypopigmentation | 1 | 2009 | 11 | 0.310 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 2009 | 47 | 0.300 |
Why?
|
| Developmental Disabilities | 3 | 2019 | 718 | 0.300 |
Why?
|
| Puberty, Precocious | 1 | 2009 | 29 | 0.300 |
Why?
|
| Ectodermal Dysplasia | 2 | 2024 | 47 | 0.300 |
Why?
|
| Community Health Workers | 2 | 2020 | 72 | 0.290 |
Why?
|
| Aneuploidy | 1 | 2009 | 139 | 0.290 |
Why?
|
| Mosaicism | 1 | 2009 | 230 | 0.270 |
Why?
|
| Craniosynostoses | 2 | 2024 | 139 | 0.260 |
Why?
|
| Mutation | 6 | 2024 | 5947 | 0.250 |
Why?
|
| Heterozygote | 2 | 2024 | 690 | 0.210 |
Why?
|
| Curriculum | 3 | 2021 | 766 | 0.210 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2016 | 3264 | 0.200 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2024 | 155 | 0.190 |
Why?
|
| Humans | 26 | 2024 | 127201 | 0.180 |
Why?
|
| Surveys and Questionnaires | 5 | 2020 | 3930 | 0.180 |
Why?
|
| Proteins | 2 | 2019 | 1019 | 0.170 |
Why?
|
| Needs Assessment | 2 | 2019 | 170 | 0.170 |
Why?
|
| DNA Mutational Analysis | 2 | 2012 | 781 | 0.160 |
Why?
|
| Dynamins | 1 | 2019 | 44 | 0.150 |
Why?
|
| Office Visits | 1 | 2018 | 79 | 0.140 |
Why?
|
| Child | 11 | 2024 | 25277 | 0.140 |
Why?
|
| Female | 17 | 2024 | 68579 | 0.130 |
Why?
|
| Adult | 11 | 2020 | 30513 | 0.130 |
Why?
|
| Health Education | 1 | 2019 | 224 | 0.130 |
Why?
|
| Patient Education as Topic | 1 | 2020 | 456 | 0.130 |
Why?
|
| Education | 1 | 2018 | 107 | 0.130 |
Why?
|
| Sexual Development | 1 | 2016 | 25 | 0.130 |
Why?
|
| Brain Diseases | 1 | 2019 | 283 | 0.120 |
Why?
|
| Steroidogenic Factor 1 | 1 | 2016 | 35 | 0.120 |
Why?
|
| Primary Ovarian Insufficiency | 1 | 2016 | 37 | 0.120 |
Why?
|
| Healthcare Disparities | 1 | 2020 | 490 | 0.110 |
Why?
|
| Seizures | 1 | 2019 | 847 | 0.110 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2019 | 526 | 0.110 |
Why?
|
| Craniofacial Abnormalities | 2 | 2019 | 252 | 0.110 |
Why?
|
| Nerve Tissue Proteins | 1 | 2019 | 1098 | 0.100 |
Why?
|
| Child, Preschool | 7 | 2024 | 14444 | 0.100 |
Why?
|
| Qualitative Research | 2 | 2016 | 659 | 0.100 |
Why?
|
| DNA Polymerase gamma | 1 | 2012 | 16 | 0.090 |
Why?
|
| Neoplasms | 2 | 2020 | 2856 | 0.090 |
Why?
|
| Ovarian Diseases | 1 | 2012 | 24 | 0.090 |
Why?
|
| Glutarates | 1 | 2012 | 39 | 0.090 |
Why?
|
| Male | 13 | 2024 | 62767 | 0.090 |
Why?
|
| Mental Disorders | 1 | 2019 | 862 | 0.090 |
Why?
|
| Eye Enucleation | 1 | 2011 | 30 | 0.090 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2015 | 459 | 0.090 |
Why?
|
| DNA, Neoplasm | 1 | 2011 | 284 | 0.080 |
Why?
|
| Genetics, Medical | 1 | 2011 | 116 | 0.080 |
Why?
|
| Risk Management | 1 | 2011 | 65 | 0.080 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 899 | 0.080 |
Why?
|
| Age of Onset | 1 | 2012 | 611 | 0.080 |
Why?
|
| Osteochondrodysplasias | 1 | 2010 | 66 | 0.080 |
Why?
|
| Syndrome | 2 | 2011 | 1137 | 0.080 |
Why?
|
| Texas | 4 | 2020 | 3564 | 0.080 |
Why?
|
| Phenotype | 2 | 2024 | 4307 | 0.080 |
Why?
|
| Genome, Human | 1 | 2015 | 1279 | 0.070 |
Why?
|
| Referral and Consultation | 1 | 2012 | 561 | 0.070 |
Why?
|
| Chromosome Aberrations | 1 | 2011 | 570 | 0.070 |
Why?
|
| Models, Molecular | 1 | 2012 | 1058 | 0.070 |
Why?
|
| DNA-Binding Proteins | 1 | 2016 | 1891 | 0.070 |
Why?
|
| Radiography | 1 | 2010 | 753 | 0.070 |
Why?
|
| Rare Diseases | 1 | 2010 | 201 | 0.070 |
Why?
|
| Retrospective Studies | 2 | 2020 | 17043 | 0.070 |
Why?
|
| DNA Repair | 1 | 2011 | 549 | 0.070 |
Why?
|
| Physicians | 2 | 2011 | 622 | 0.070 |
Why?
|
| Mutation, Missense | 3 | 2019 | 891 | 0.070 |
Why?
|
| Patient Care Team | 1 | 2011 | 551 | 0.070 |
Why?
|
| Infant | 4 | 2024 | 12801 | 0.060 |
Why?
|
| Ovarian Neoplasms | 1 | 2011 | 443 | 0.060 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2024 | 49 | 0.050 |
Why?
|
| Limb Deformities, Congenital | 1 | 2024 | 109 | 0.050 |
Why?
|
| Young Adult | 2 | 2019 | 9693 | 0.050 |
Why?
|
| Follow-Up Studies | 1 | 2010 | 5139 | 0.040 |
Why?
|
| Pedigree | 2 | 2016 | 1656 | 0.040 |
Why?
|
| Medical History Taking | 1 | 2020 | 108 | 0.040 |
Why?
|
| Self Efficacy | 1 | 2020 | 198 | 0.040 |
Why?
|
| Perception | 1 | 2021 | 227 | 0.040 |
Why?
|
| Awareness | 1 | 2019 | 78 | 0.040 |
Why?
|
| Exome | 2 | 2015 | 1064 | 0.040 |
Why?
|
| Peroxisomes | 1 | 2019 | 41 | 0.040 |
Why?
|
| Muscles | 1 | 2019 | 222 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2011 | 8363 | 0.040 |
Why?
|
| Breast Neoplasms | 1 | 2011 | 2583 | 0.040 |
Why?
|
| Decision Making | 2 | 2016 | 666 | 0.040 |
Why?
|
| GTP Phosphohydrolases | 1 | 2019 | 157 | 0.040 |
Why?
|
| Language Development Disorders | 1 | 2019 | 177 | 0.040 |
Why?
|
| Base Sequence | 2 | 2012 | 2759 | 0.030 |
Why?
|
| Neuroglia | 1 | 2019 | 208 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2020 | 881 | 0.030 |
Why?
|
| Psychometrics | 1 | 2021 | 656 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 2019 | 398 | 0.030 |
Why?
|
| Behavior, Animal | 1 | 2019 | 494 | 0.030 |
Why?
|
| Sex Determination Processes | 1 | 2016 | 10 | 0.030 |
Why?
|
| Karyotype | 1 | 2016 | 29 | 0.030 |
Why?
|
| Androgen-Insensitivity Syndrome | 1 | 2016 | 26 | 0.030 |
Why?
|
| Gonads | 1 | 2016 | 32 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2020 | 1400 | 0.030 |
Why?
|
| Autistic Disorder | 1 | 2019 | 363 | 0.030 |
Why?
|
| Pathology, Molecular | 1 | 2015 | 63 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2016 | 324 | 0.030 |
Why?
|
| Alleles | 1 | 2019 | 1609 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 2891 | 0.030 |
Why?
|
| Testis | 1 | 2016 | 405 | 0.030 |
Why?
|
| Mitochondria | 1 | 2019 | 730 | 0.030 |
Why?
|
| United States | 2 | 2019 | 11360 | 0.030 |
Why?
|
| Drosophila melanogaster | 1 | 2019 | 809 | 0.030 |
Why?
|
| Drosophila Proteins | 1 | 2019 | 757 | 0.030 |
Why?
|
| Intellectual Disability | 1 | 2019 | 1048 | 0.020 |
Why?
|
| Epilepsy | 1 | 2019 | 844 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2019 | 1569 | 0.020 |
Why?
|
| Hedgehog Proteins | 1 | 2012 | 197 | 0.020 |
Why?
|
| Siblings | 1 | 2012 | 202 | 0.020 |
Why?
|
| Chromosome Breakage | 1 | 2011 | 156 | 0.020 |
Why?
|
| Cytoskeletal Proteins | 1 | 2012 | 273 | 0.020 |
Why?
|
| Genes, BRCA2 | 1 | 2011 | 48 | 0.020 |
Why?
|
| Genes, BRCA1 | 1 | 2011 | 59 | 0.020 |
Why?
|
| Homozygote | 1 | 2012 | 540 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 2011 | 155 | 0.020 |
Why?
|
| Bone and Bones | 1 | 2012 | 295 | 0.020 |
Why?
|
| Middle Aged | 2 | 2020 | 27789 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2011 | 282 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2011 | 748 | 0.020 |
Why?
|
| Neurons | 1 | 2019 | 1921 | 0.020 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2011 | 560 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2012 | 578 | 0.020 |
Why?
|
| DNA Replication | 1 | 2011 | 347 | 0.020 |
Why?
|
| Risk | 1 | 2011 | 736 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2019 | 6240 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2012 | 2543 | 0.020 |
Why?
|
| Brain | 1 | 2019 | 3039 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2011 | 3587 | 0.020 |
Why?
|
| Adolescent | 1 | 2019 | 20135 | 0.010 |
Why?
|
| Animals | 1 | 2019 | 33185 | 0.010 |
Why?
|